Cleara Biotech B.V

Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence. Through detailed understanding of the molecular and biological pathways that underlie these individual pathological phenotypes, we set up disruptive, innovative and proprietary platform technology to design and optimize (peptide-based) therapeutics that exploit their weak spots for safe and selective clearance. Clearas lead FOXO4 program is focused on generation of disruptive and proprietary technology against scarred cellular senescence for treatment of metastatic, mutant-p53 cancer. Senescent cells are associated with a range of chronic diseases and...

Senescence,cancer,peptides,drug development,r&d,life sciences,aging,preclinical development,colon cancer,and breast cancer

Cleara biotech b.v operates in the Biotechnology research industry.

Cleara biotech b.v's revenue is 11m - 100m

Cleara biotech b.v has 11 - 50 employees.